Clinical Trials Sponsored by Bangkok Drug company

Total 50 results

Thammasat University
Bangkok Drug company

Completed

Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic Neuropathy

Diabetic Polyneuropathy

Thailand
Khon Kaen University
and Bangkok drugs Co.

Completed

Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 14% of Plai (Plaivana®) to Placebo Gels (OA knee Plai)

Knee Osteoarthritis

Thailand
Eli Lilly and Company
i3 Drug Safety

Completed

Safety Study of Atomoxetine and Cerebrovascular Outcomes

Transient Ischemic Attack | ADHD | Cerebrovascular Accident

United States
AstraZeneca
Eli Lilly and Company; i3 Drug Safety

Completed

A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents

Type 2 Diabetes (Treated With Exenatide or Other Oral Antidiabetic Therapies) | Healthy Subjects (Treated With no Diabetes Therapies)

United States
Kaiser Permanente
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial (PROUD)

Opioid-use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Opioid Use Disorder in the Emergency Department: CTN 0069

Opioid Use Disorder

United States
Duke University
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075 (Pharm-OUD-Care)

Opioid Use Disorder

United States
Government Dental College and Research Institute...
Himalaya Drug Company Ltd. India

Completed

Clinical and Microbiological Efficacy of Systemic Ayurvedic Immunomodulator Septilin in the Treatment of Chronic Periodontitis

Chronic Periodontitis

India
Drug Delivery Company, LLC DBA Akyso Pharmaceuticals
National Institute on Drug Abuse (NIDA); Laboratory Corporation of America; Cognitive...

Not yet recruiting

A Phase 1, Placebo-controlled, Single-Ascending-Dose, Study of BIOPIN 6 in Healthy Adults

Opioid Use Disorder
NYU Langone Health
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Opioid Use Disorder

United States
Hennepin Healthcare Research Institute
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Recruiting

EXHIT ENTRE Comparative Effectiveness Trial (EXHITENTRE)

Substance Use Disorder | Opioid Use Disorder, Moderate | Opioid Use Disorder, Severe

United States
Hennepin Healthcare Research Institute
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Recruiting

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy (EXHITENTRE)

Substance Use Disorders | Opioid Use Disorder, Moderate | Opioid Use Disorder, Severe

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC; National Drug...

Completed

Peer Intervention to Link Overdose Survivors to Treatment (PILOT) (PILOT)

Opioid Overdose

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Cocaine Use Reduction With Buprenorphine (CURB)

Cocaine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone (SWIFT)

Opioid-use Disorder

United States
Sharon Walsh
National Institute on Drug Abuse (NIDA); Eli Lilly and Company

Completed

Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial

Substance Abuse

United States
Government Dental College and Research Institute...
Himalaya Drug Company Research and Development, Makali, Bangalore, India

Completed

Comparison Of Clinical Efficacy Of A Herbal And A Non-Herbal Mouthwash On Dentinal Hypersensitivity

Dentinal Hypersensitivity
National Institute on Drug Abuse (NIDA)
Technical Resources International, Inc.; Promentis Pharmaceuticals, Inc.; Altasciences...

Not yet recruiting

SXC-2023 Cocaine Interaction Study

Cocaine Use Disorder

United States
University of Texas Southwestern Medical Center
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder (ADAPT-2)

Methamphetamine Use Disorder

United States
Columbia University
National Institute on Drug Abuse (NIDA); University of Miami; Emory University; The Emmes Company, LLC

Recruiting

Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders Among Hospitalized Patients (CTN0121)

Substance Use Disorders | Injection Site Infection

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study (MOMs-CMA)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
Boston Children's Hospital
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC; Friends Research...

Completed

Adolescent SCreening To Help Eliminate Misuse (ASC-THEM)

Substance Use

United States
Walter Ling
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder (ADAPT)

Methamphetamine Use Disorder

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study (MOMs-INO)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Neonatal Opiate Withdrawal Syndrome | Drug Abuse in Pregnancy

United States
T. John Winhusen, PhD
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Active, not recruiting

Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs)

Pregnancy Related | Opioid-Related Disorders | Substance Abuse | Drug Abuse | Drug Addiction | Neonatal Abstinence Syndrome | Drug Abuse in Pregnancy | Neonatal Opioid Withdrawal Syndrome

United States
Jiangsu Renocell Biotech Company
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...

Recruiting

RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

Lupus Nephritis

China
Jiangsu Renocell Biotech Company
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical...

Recruiting

RY_SW01 Cell Injection Therapy in Systemic Sclerosis

Systemic Sclerosis

China
HealthPartners Institute
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC; Geisinger Clinic and other collaborators

Completed

Clinical Decision Support for Opioid Use Disorders in Medical Settings (COMPUTE 2.0)

Opioid-use Disorder

United States
Go Medical Industries Pty Ltd
National Institute on Drug Abuse (NIDA); Columbia University; University at Buffalo and other collaborators

Not yet recruiting

Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons (GM0020)

Opioid Use Disorder
Duke University
Food and Drug Administration (FDA); Medtronic; Abbott Medical Devices; The Medicines... and other collaborators

Terminated

SAFE-PCI for Women (SAFE-PCI)

Percutaneous Coronary Intervention | Ischemic Symptoms
NYU Langone Health
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Recruiting

Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Opioid Use Disorder (OUD)

United States
Yale University
Harvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaborators

Recruiting

Emergency Department-Initiated Buprenorphine Validation Network Trial

Opioid-use Disorder

United States
Stanford University
United States Department of Defense; Department of Health and Human Services; Food and Drug Administration (FDA) and other collaborators

Completed

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1 (ETA-TV)

Eye-tracking

United States
Stanford University
United States Department of Defense; Department of Health and Human Services; Food and Drug Administration (FDA) and other collaborators

Terminated

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2 (ETA-TV)

Eye-tracking

United States
Liverpool John Moores University
Institute of Naval Medicine (UK); CTCRM Lympstone (UK); University of Portsmouth... and other collaborators

Recruiting

Risk Factors for Exertional Heat Illness

Exertional Heat Illness

United Kingdom
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); University of California, San Francisco and other collaborators

Not yet recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Opioid Use Disorder
Yih-Ing Hser
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Not yet recruiting

Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) (RXR)

Substance-Related Disorders | Opioid-Related Disorders | Narcotic-Related Disorders

United States
Air Force Military Medical University, China
The People's Hospital of Hebei Province; Bethune International Peace Hospital; Second Hospital of Jilin University and other collaborators

Unknown

Impact of Benfluorex Versus Metformin on Glucose Control and Insulin Secretion in Chinese Type 2 Diabetic Patients

Type 2 Diabetes

China
China National Biotec Group Company Limited
Peking University; Beijing Institute of Biological Products Co Ltd.; Sichuan... and other collaborators

Completed

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP

Vaccination

China
China National Biotec Group Company Limited
Peking University; Beijing Institute of Biological Products Co Ltd.; Sichuan... and other collaborators

Unknown

Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR

Vaccine

China
China National Biotec Group Company Limited
Peking University; Wuhan Institute of Biological Products Co., Ltd; Guizhou Center... and other collaborators

Completed

Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza Vaccine

Enterovirus Infections | Influenza

China
China National Biotec Group Company Limited
Peking University; Hunan Provincial Center for Disease Control and Prevention; Guizhou Center for Disease Control and Prevention and other collaborators

Completed

Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4

Pneumonia, Pneumococcal | Influenza, Human

China
Columbia University
National Institute on Drug Abuse (NIDA); Medical University of South Carolina; University of Pittsburgh and other collaborators

Completed

HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S. (Aware)

HIV/AIDS | Sexually Transmitted Infections

United States
The First Affiliated Hospital of Soochow University
West China Hospital; Affiliated Hospital of Jiangnan University; The Affiliated... and other collaborators

Recruiting

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

China
Columbia University
Boston University; National Institute on Drug Abuse (NIDA); Johns Hopkins University and other collaborators

Completed

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S. (CTN 0064)

Hepatitis C | HIV | Substance Use | AIDS

United States
Tongji Hospital
Wuhan University; First Affiliated Hospital of Fujian Medical University; The... and other collaborators

Recruiting

The Dose Range of Remimazolam Besylate in Different Age Groups

Anesthesia | Remimazolam

China
China-Japan Friendship Hospital
Xijing Hospital; Changhai Hospital; The First Affiliated Hospital of Anhui Medical... and other collaborators

Recruiting

Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China (NM-in-RCIP)

Nutritional Deficiency

China
RenJi Hospital
The First Affiliated Hospital with Nanjing Medical University; Peking University... and other collaborators

Recruiting

Application Circulating Tumor DNA Dynamic Monitoring in Clinical Treatment of Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

China
Beijing Tiantan Hospital
The First Affiliated Hospital of Anhui Medical University; West China Hospital and other collaborators

Recruiting

Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China (MATCH)

Brain Arteriovenous Malformation

China
Ruijin Hospital
The First Affiliated Hospital with Nanjing Medical University; Shanxi Province... and other collaborators

Not yet recruiting

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types

Lymphoma | Marginal Zone Lymphoma | Anaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Diffuse Large B Cell Lymphoma | Mucosa-Associated Lymphoid Tissue Lymphoma | Intravascular Large B-Cell Lymphoma | Extranodal Lymphoma | NK/T-Cell Lymphoma, Nasal and Nasal-Type

China

Clinical Trials Sponsored by Bangkok Drug company

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations